South Korea Non-Small Cell Lung Cancer Diagnostics Market (2025-2031) | Industry, Size & Revenue, Outlook, Segmentation, Competitive Landscape, Value, Growth, Share, Forecast, Companies, Analysis, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle

3.4 South Korea Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces

3.5 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.6 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F

3.8 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of non-small cell lung cancer in South Korea

4.2.2 Advancements in diagnostic technologies for early detection

4.2.3 Growing awareness about the importance of early screening for lung cancer

4.3 Market Restraints

4.3.1 High cost associated with advanced diagnostic tests

4.3.2 Limited access to specialized diagnostic facilities in rural areas

6.1 South Korea Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type

6.1.1 Overview and Analysis

6.1.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F

6.1.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F

6.1.4 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F

6.1.5 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F

6.1.6 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market, By Product

6.2.1 Overview and Analysis

6.2.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F

6.2.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F

6.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market, By Test

6.3.1 Overview and Analysis

6.3.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F

6.3.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F

6.3.4 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F

6.3.5 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F

6.3.6 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F

6.3.7 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F

6.4 South Korea Non-Small Cell Lung Cancer Diagnostics Market, By End-User

6.4.1 Overview and Analysis

6.4.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F

6.4.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F

6.4.4 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F

6.4.5 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7.1 South Korea Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries

7.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries

8.1 Average age of diagnosis for non-small cell lung cancer patients in South Korea

8.2 Percentage of non-small cell lung cancer cases diagnosed at an early stage

8.3 Adoption rate of advanced diagnostic technologies in South Korea

9.1 South Korea Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 South Korea Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F

9.4 South Korea Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 South Korea Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 South Korea Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters